Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02505516
Recruitment Status : Completed
First Posted : July 22, 2015
Last Update Posted : July 22, 2015
Sponsor:
Information provided by (Responsible Party):
UFUOMA MILLER FAKPOR, University of Cape Coast

Brief Summary:
patients om metformin from diabetic clinic were checked for bladder cancer

Condition or disease Intervention/treatment Phase
Bladder Cancer Diabetes Other: metformin Early Phase 1

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 150 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single (Participant)
Primary Purpose: Screening
Official Title: BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS ON METFORMIN THERAPY IN A WEST AFRICA SUB-REGION
Study Start Date : June 2013
Actual Primary Completion Date : January 2014
Actual Study Completion Date : February 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Bladder Cancer

Arm Intervention/treatment
Placebo Comparator: metformin
metformin 500mg
Other: metformin
Other Name: glucophage

No Intervention: not on metformin



Primary Outcome Measures :
  1. Number of diabetic patients on metformin therapy [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   25 Years to 86 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 150 people attending diabetic clinic

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02505516


Locations
Layout table for location information
Ghana
Universty of Capecoast
Cape Coast, Ghana
Sponsors and Collaborators
UFUOMA MILLER FAKPOR

Layout table for additonal information
Responsible Party: UFUOMA MILLER FAKPOR, miss, University of Cape Coast
ClinicalTrials.gov Identifier: NCT02505516     History of Changes
Other Study ID Numbers: 021
First Posted: July 22, 2015    Key Record Dates
Last Update Posted: July 22, 2015
Last Verified: July 2015

Keywords provided by UFUOMA MILLER FAKPOR, University of Cape Coast:
pathology

Additional relevant MeSH terms:
Layout table for MeSH terms
Urinary Bladder Neoplasms
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Urinary Bladder Diseases
Urologic Diseases
Metformin
Hypoglycemic Agents
Physiological Effects of Drugs